Recent Updates
Recently added Catalysts

Fluviral influenza vaccine, 2009-2010

Phase 3

Influenza | Monoclonal antibody | Infectious Disease |GSK plc|Last Updated: Apr 20, 2012

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedDouble-BlindPLACEBO_CONTROLLEDDMC
Total Trials1
Total Enrollment468
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT01001325Does Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?PHASE3 COMPLETED 468Oct 1, 2009Jul 1, 2010Apr 20, 20122 Canada
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Number of pH1N1 Influenza Infections as Diagnosed by PCR From Mid-turbinate Swab
day +7 post seasonal influenza vaccination (or placebo) to end of study

Influenza infection (pH1N1) as diagnosed by PCR from self-collected mid-turbinate swab. Participant is asked to collect a swab when they have symptoms possibly compatible with an acute viral respiratory illness: 1) fever without another obvious source, 2) at least two new respiratory symptoms (runny or stuffy nose, sneezing, sore or scratchy throat, hoarseness, cough), or 3) one respiratory symptom (as above) and one systemic symptom (fever, malaise, muscle aches, headache, fatigue)

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingQUADRUPLE
ModelPARALLEL
PurposeHEALTH_SERVICES_RESEARCH
Treatment Arms
ArmTypeDescription
Seasonal influenza vaccinationEXPERIMENTALReceipt of Fluviral seasonal (2009-2010, Canadian) influenza vaccination as per manufacturers specification
PlaceboPLACEBO_COMPARATOR0.5 mL normal saline
Interventions
NameTypeDescription
Fluviral influenza vaccine, 2009-2010BIOLOGICAL0.5 mL intramuscular
Normal salineBIOLOGICAL0.5 mL intramuscular
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 60 Years
SexALL
Healthy VolunteersYes
Study Sites2

Inclusion Criteria: 1. 18 to 60 years old, inclusive, as of September 1st, 2009; 2. understand the study, agree to its provisions, and give written informed consent prior to entry; 3. available for follow-up during the study period; 4. have convenient access to a computer with internet access and b...

Countries:Canada
Unlock Eligibility Criteria